No. 166 Squadron RAF

Implicity Simplifies Cardiac RPM Workflows with New InLink Solution

Retrieved on: 
Tuesday, April 18, 2023

CAMBRIDGE, Mass., April 18, 2023 /PRNewswire/ -- Implicity, a leader in remote patient monitoring and cardiac data management solutions, introduced the immediate availability of InLink, a new in-clinic tool that streamlines remote cardiac monitoring workflows.

Key Points: 
  • In-clinic tool automatically and securely links manufacturer programmers with Implicity's data management solution for faster, more efficient remote monitoring workflows
    CAMBRIDGE, Mass., April 18, 2023 /PRNewswire/ -- Implicity , a leader in remote patient monitoring and cardiac data management solutions, introduced the immediate availability of InLink, a new in-clinic tool that streamlines remote cardiac monitoring workflows.
  • The transmissions now happen automatically, saving clinicians valuable time they can dedicate back to patient care," said Ad́élie Cerrato, Product Manager at Implicity.
  • "When you consider some cardiac clinics seeing over 50 patients daily, the benefits of InLink are substantial.
  • "This is yet another example of Implicity delivering innovative, practical solutions that help unify RPM workflows, improve the lives of clinicians and enable better more effective cardiac care."

Implicity Introduces New Algorithm to Address Alert Fatigue in AF Care

Retrieved on: 
Wednesday, April 12, 2023

CAMBRIDGE, Mass., April 12, 2023 /PRNewswire/ -- Implicity, a leader in remote patient monitoring and cardiac data management solutions, introduced a new algorithm designed to reduce alert fatigue in the remote monitoring of patients with atrial fibrillation (AF).

Key Points: 
  • Implicity's AF Alert Management feature addresses AF burden, reducing alerts for patients who are taking anticoagulants and have a low risk of complications while triggering notifications the moment there is a significant change in a patient's condition that requires intervention or adjustments to treatment.
  • "The AF Alert Management tool optimizes AFib burden management, allowing providers to focus on clinically significant events," said Adélie Cerrato, Product Manager at Implicity.
  • This, in turn, can lead to better patient outcomes as they receive appropriate care when needed."
  • Implicity's algorithm works with any device that collects atrial burden trends data and can classify the following scenarios in line with ESC recommendations:

Implicity to Participate in Health Tech Challengers Super Finals at HLTH 2022

Retrieved on: 
Tuesday, November 8, 2022

CAMBRIDGE, Mass., Nov. 8, 2022 /PRNewswire/ -- Implicity®, a leader in remote patient monitoring and cardiac data management solutions, announced it has been selected to participate in the Health Tech Challengers (HTC) Super Finals taking place live at HLTH 2022.

Key Points: 
  • Company named a Top 8 Super Finalist in the global health tech competition identifying the most disruptive companies shaping the future of digital health.
  • CAMBRIDGE, Mass., Nov. 8, 2022 /PRNewswire/ -- Implicity , a leader in remote patient monitoring and cardiac data management solutions, announced it has been selected to participate in the Health Tech Challengers (HTC) Super Finals taking place live at HLTH 2022.
  • Implicity develops unique AI and knowledge-based algorithms with the potential to predict patient health status, which reduce the workload on healthcare professionals.
  • Implicity proudly protects more than 60,000 patients in 100 medical facilities across the United States and Europe.For more information, visit: www.implicity.com .

Global Patient Monitoring Devices Market Report 2022: Technological Advancements and Rising Disease Incidence to Drive Demand - ResearchAndMarkets.com

Retrieved on: 
Tuesday, October 25, 2022

The global patient monitoring devices market is anticipated to grow at a CAGR of 9.1% to reach USD 65.4 billion by 2027 from USD 42.3 billion in 2022.

Key Points: 
  • The global patient monitoring devices market is anticipated to grow at a CAGR of 9.1% to reach USD 65.4 billion by 2027 from USD 42.3 billion in 2022.
  • However, the high cost associated with novel and advanced monitoring devices is expected to limit the market growth.
  • Based on the product, the patient monitoring devices market is segmented into multiparameter monitoring devices, temperature monitoring devices, blood glucose monitoring systems, fetal and neonatal monitoring devices, neuromonitoring devices, weight monitoring devices, cardiac monitoring devices, hemodynamic/pressure monitoring devices, respiratory monitoring devices, and other patient monitoring devices.
  • By end-users, the patient monitoring devices market is segmented into home care settings, hospitals, ambulatory surgery centers, and other end-users.

Patient Monitoring Devices Market Global Key Players, Demands, Size, Share, Products, Trend, Growth Rate and Forecasts to 2027 -ReportsnReports

Retrieved on: 
Thursday, September 29, 2022

The patient monitoring devices market is anticipated to grow at a CAGR of 9.1% to reach USD 65.4 billion by 2027 from USD 42.3 billion in 2022.

Key Points: 
  • The patient monitoring devices market is anticipated to grow at a CAGR of 9.1% to reach USD 65.4 billion by 2027 from USD 42.3 billion in 2022.
  • However, the high cost associated with novel and advanced monitoring devices is expected to limit the market growth.
  • Based on the product, the patient monitoring devices market is segmented into multiparameter monitoring devices, temperature monitoring devices, blood glucose monitoring systems, fetal and neonatal monitoring devices, neuromonitoring devices, weight monitoring devices, cardiac monitoring devices, hemodynamic/pressure monitoring devices, respiratory monitoring devices, and other patient monitoring devices.
  • By end-users, the patient monitoring devices market is segmented into home care settings, hospitals, ambulatory surgery centers, and other end users.

Implicity Continues Rapid Growth and Expansion with Hiring of Two New Senior Leaders

Retrieved on: 
Wednesday, September 28, 2022

CAMBRIDGE, Mass., Sept. 28, 2022 /PRNewswire/ -- Implicity®, a leader in remote patient monitoring and cardiac data management solutions, announced its continued growth with the appointment of two new senior-level executives. Vanessa Joyce was named the Company's new Vice President of Sales for North America, and Megan Grosz was appointed Global Head of Marketing and Communications.

Key Points: 
  • Both Vanessa and Megan bring a wealth of industry knowledge to support our rapid global expansion, particularly in the U.S.where we see a dramatic rise in remote patient monitoring," said Dr. Arnaud Rosier, Electrophysiologist, CEO, and Co-founder of Implicity.
  • Vanessa Joyce comes to Implicity with more than 30 years of experience in MedTech marketing and clinical aspects ofthe Cardiac, Heart Failure, and Electrophysiology industries.
  • "I'm excited to apply my expertise and experience to establish Implicity as the primary CIED remote monitoring software solution," said Joyce.
  • Implicity proudly protects more than 70,000 patients in more than 100 medical facilities across the United States and Europe.

New Analysis from Global Industry Analysts Reveals Steady Growth for Cardiac Monitoring Devices, with the Market to Reach $8.6 Billion Worldwide by 2026

Retrieved on: 
Tuesday, June 28, 2022

SAN FRANCISCO, June 28, 2022 /PRNewswire/ -- A new market study published by Global Industry Analysts Inc., (GIA) the premier market research company, today released its report titled "Cardiac Monitoring Devices - Global Market Trajectory & Analytics" .

Key Points: 
  • SAN FRANCISCO, June 28, 2022 /PRNewswire/ -- A new market study published by Global Industry Analysts Inc., (GIA) the premier market research company, today released its report titled "Cardiac Monitoring Devices - Global Market Trajectory & Analytics" .
  • Previews provide deep insider access to business trends; competitive brands; domain expert profiles; and market data templates and much more.
  • Preview Registry
    Amid the COVID-19 crisis, the global market for Cardiac Monitoring Devices estimated at US$5.8 Billion, is projected to reach a revised size of US$8.6 Billion by 2026, growing at a CAGR of 6.6% over the analysis period.
  • Global Industry Analysts, Inc., ( www.strategyr.com ) is a renowned market research publisher the world`s only influencer driven market research company.

Implicity Receives FDA Clearance for AI-Powered ECG Analyzer for Implantable Loop Recorders

Retrieved on: 
Thursday, December 16, 2021

CAMBRIDGE, Mass., Dec. 16, 2021 /PRNewswire/ -- Implicity , a leader in remote patient monitoring and cardiac data management solutions, today announced FDA clearance for a novel medicalalgorithm that analyzes ECG data from Implantable Loop Recorders (ILRs).

Key Points: 
  • CAMBRIDGE, Mass., Dec. 16, 2021 /PRNewswire/ -- Implicity , a leader in remote patient monitoring and cardiac data management solutions, today announced FDA clearance for a novel medicalalgorithm that analyzes ECG data from Implantable Loop Recorders (ILRs).
  • The newly 510(k) cleared ILR ECG Analyzer is an algorithm based on artificial intelligence, representing a breakthrough innovation in the cardiology sector.
  • "This is an important step for Implicity as we expand in the US market," said Dr. Arnaud Rosier, CEO and founder of Implicity.
  • "With FDA clearance, our AI product can now be used in combination with implantable loop recorders to improve arrhythmia detection and help electrophysiologists and their teams avoid wasting time reviewing non-actionable events."

Global Implantable Loop Recorders Market (2021 to 2026) - Growth, Trends, COVID-19 Impact and Forecasts - ResearchAndMarkets.com

Retrieved on: 
Friday, September 24, 2021

Increasing incidences of atrial fibrillation is one of the major factors driving the demand for implantable loop recorders.

Key Points: 
  • Increasing incidences of atrial fibrillation is one of the major factors driving the demand for implantable loop recorders.
  • Implantable loop recorders (ILRs) aid in improving the long-term ECG monitoring and the diagnosis of atrial fibrillation after a stroke.
  • Therefore, such patients undergo a minor surgery for implantation of loop recorders to reduce the consequences of atrial fibrillation.
  • Thus, in view of the above-mentioned factors, the implantable loop recorders market is anticipated to grow significantly over the forecast period in North America.